Ultrafiltration and dry weight - What are the cardiovascular effects?

Artificial Organs

Volumn 27, Issue 3, 2003, Pages 227-229

  Stegmayr, Bernd G ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular effects; Dry weight; Hemodialysis; Ultrafiltration

Indexed keywords

BLOOD PRESSURE; CARDIOLOGY; CELL DEATH; DIAGNOSIS; DISEASES; HEART; HEMODIALYZERS; PATHOLOGY; ULTRAFILTRATION;

CARDIOVASCULAR EFFECT; CONDITION; CONGESTIVE HEART FAILURES; DIALYSATES; DRY WEIGHT; END-STAGE RENAL DISEASE; HAEMODIALYSIS; HEALTHY CONTROLS; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR;

DIALYSIS;

ALBUMIN; CALCIUM; HEMOGLOBIN; POTASSIUM;

ANEMIA; ASPIRATION PNEUMONIA; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CELL DEATH; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIALYSATE; DIALYSIS; DISEASE EXACERBATION; DRY WEIGHT; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPOTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MALNUTRITION; MORBIDITY; NEUROLOGICAL COMPLICATION; PERFUSION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; ULTRAFILTRATION; URINE VOLUME; VASCULAR ACCESS; WATER RETENTION;

GOES;

EID: 0037359208     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07205.x     Document Type: Conference Paper

References (16)

1. Parfrey PS, Foley RN. Cardiac disease in dialysis patients. In: Owen WF, Pereira BJG, Sayegh MH, eds. Dialysis and transplantation. Philadelphia: W.B. Saunders Company, 2000:221-37.
2. Kapoian T, Sherman RA. Long-term care of the patient undergoing dialysis. Intradialytic complications. In: MH. S., ed. Dialysis and transplantation. Philadelphia: W.B. Saunders Company, 2000:199-220.
3. Venkataraman V, Nolph KD. Preservation of residual renal function - an important goal. Perit Dial Int 2000;20:392-5.
4. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med 1980;69:576-84.
5. Schön S, Ahlmen J, Wikström B, Ekberg H. Swedish Registry for Active Uremia-therapy. SRAU 1991-2000. Skövde, Sweden: Njurmedicinska kliniken, Kärnsjukhuset, 2001.
6. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-92.
7. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001;38:992-1000.
8. Yang CS, Chen SW, Chiang CH, Wang M, Peng SJ, Kan YT. Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patients. Am J Kidney Dis 1996;27:380-6.
9. Lowrie EG, Huang WH, Lew NL. Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison. Am J Kidney Dis 1995;26:220-8.
10. Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 2001;19:53-61.
11. Stegmayr BG, Banga R, Lundberg L, Wikdahl AM, Plum-Wirell M. PD treatment for severe congestive heart failure. Perit Dial Int 1996;16(Suppl1):S231-5.
12. Mehrotra R, Khanna R. Peritoneal ultrafiltration for chronic congestive heart failure: rationale, evidence and future. Cardiology 2001;96:177-82.
13. Ryckelynck JP, Lobbedez T, Valette B, et al. Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 1998;13(Suppl4):56-9.
14. Elhalel-Dranitzki M, Rubinger D, Moscovici A, et al. CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transplant 1998;13:3041-2.
15. Ragazzoni E, Sacco A, Cusinato S, et al. [Heart failure resistant to drug therapy. Nephrologic approach]. Minerva Urol Nefrol 1998;50:133-8.
16. Katzarski KS, Nisell J, Randmaa I, Danielsson A, Freyschuss U, Bergstrom J. A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis 1997;30:459-65.